Nationwide survey in <scp>J</scp>apan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis <scp>C</scp> virus‐related chronic liver disease in patients with low platelet count
Naoto Ikeda(Hyogo Medical University), Shuhei Nishiguchi(Osaka City General Hospital), Hirayuki Enomoto(Hyogo Medical University), Masatoshi Kudo(Kindai University), Nobuhiro Aizawa(Hyogo Medical University), Hiroko Iijima(Hyogo University), Masaki Saito(Gunma University), Satoshi Yamamoto(Hyogo Medical University), Hironori Tanaka(Hyogo Medical University), Yoshinori Iwata(Hyogo Medical University), Hiroyasu Imanishi(Hyogo Medical University), Shigeki Arii(Kyoto University), Yuji Iimuro(Yamanashi Prefectural Central Hospital), Shozo Hirota(Hyogo Medical University), Jiro Fujimoto(Harvard University)
Cited by 10
Related Papers
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k